最少侵入性表面活性剂疗法 (MIST) 的程序结果:国际匹配队列研究
Patrick J Peebles1, Joseph G Reiter2, Paul J Wildenhain2
1University of Wisconsin School of Medicine and Public Health, Madison, WI, USA.
The Journal of pediatrics
|February 20, 2026
概括
最少侵入性表面活性剂治疗 (MIST) 显示出更好的安全性和成功性,而不是气管管道输管 (TI) 输送表面活性剂. 视频喉腔镜等因素改善了MIST的结果,使其成为一种首选的方法.
科学领域:
- 新生儿医学 新生儿医学
- 呼吸系统护理 呼吸系统护理
- 医疗设备技术 医疗设备技术
背景情况:
- 表面活性剂替代疗法对于早产婴儿的呼吸困扰综合征至关重要.
- 气管管道输入 (TI) 是传递表面活性剂的传统方法,但存在程序性风险.
- 最少侵入性表面活性剂疗法 (MIST) 提供了一个不那么侵入性的替代方案.
研究的目的:
- 为了比较MIST与TI的过程安全性和成功率,用于表面活性剂的管理.
- 确定与接受MIST的患者更好的治疗结果相关的因素.
主要方法:
- 一个回顾性,多中心,匹配的队列研究,使用国际气道注册 (2016-2024).
- 接受MIST的患者与接受TI (没有麻药) 的患者根据妊娠年龄,位置和喉镜类型进行了1:1匹配.
- 主要结局:严重的氧气脱 (>20% SpO2 减少). 二次结果: SpO2 <80%,不良事件,第一次尝试成功.
主要成果:
- 与TI相比,MIST与严重氧气不和 (aOR 0.66) 和SpO2 <80% (aOR 0.59) 的几率明显较低.
- 第一次尝试的成功率高于MIST (aOR 2.93),而不良事件发生率没有差异.
- 改善的MIST结果与视频喉腔镜,第一个呼吸道提供者,商业导管和患者体重有关.
结论:
- 与表面活性剂输送的TI相比,MIST显示出更高的程序安全性和成功率.
- 特定的程序元素,如视频喉腔镜,可以进一步提高MIST的有效性.
更多相关视频
04:21A Minimally Invasive Method for Intratracheal Instillation of Drugs in Neonatal Rodents to Treat Lung Disease
Published on: August 4, 2021
7.2K
05:39Author Spotlight: A Non-Intubated Video-Assisted Thoracoscopic Surgery with Multimodal Analgesia and Sevoflurane Inhalation Anesthesia
Published on: May 26, 2023
2.5K
相关概念视频
Breathing
50.4K
The process of breathing, inhaling and exhaling, involves the coordinated movement of the chest wall, the lungs, and the muscles that move them. Two muscle groups with important roles in breathing are the diaphragm, located directly below the lungs, and the intercostal muscles, which lie between the ribs. When the diaphragm contracts, it moves downward, increasing the volume of the thoracic cavity and creating more room for the lungs to expand. When the intercostal muscles contract, the ribs...
50.4K
Acute Respiratory Failure-V
766
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
766
